A minimally invasive treatment known as GAE (genicular artery embolization) is emerging as a viable alternative for chronic knee pain, potentially delaying or eliminating the need for knee replacement surgery. Early studies suggest the procedure can provide relief for years by reducing inflammation inside the joint.
For many patients, knee replacement has been the standard solution for osteoarthritis, but it involves significant recovery time and risk. GAE offers a less disruptive option, allowing people to return to activities like gardening and cycling without major downtime.
Initial research indicates that GAE may offer sustained pain relief, though larger long-term studies are still needed to confirm its durability. The procedure has shown promise in reducing inflammation, but not all patients may be candidates.
If broader clinical trials validate early findings, GAE could reshape treatment protocols for knee osteoarthritis. Healthcare systems might see reduced demand for joint replacement surgeries, lowering costs and recovery burdens for patients.
However, experts caution that GAE is not a cure and may not work for everyone. More research is necessary to determine who benefits most and how long relief lasts.